Investor Relations

Explore information about IDEAYA's business, strategy, pipeline, and financial performance, as well as the latest updates for the investment community.

Download IDEAYA Highlights

Stock Info
NASDAQIDYA

View all stock information

Recent News
Jun 10, 2026
IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

IDEAYA Biosciences, Inc. (Nasdaq: IDYA) today announced the closing of its underwritten public offering of 7,222,225 shares of its common stock at a public offering price of $27.00 per share,...

Jun 8, 2026
IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants

IDEAYA Biosciences, Inc. (Nasdaq:IDYA) today announced the pricing of an underwritten public offering of common stock and pre-funded warrants. IDEAYA is selling 5,555,556 shares of common stock...

Jun 8, 2026
IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

IDEAYA Biosciences, Inc. (Nasdaq: IDYA) today announced that it intends to offer and sell up to $300.0 million of shares of its common stock and, in lieu of common stock, to offer and sell to...

All Releases

Events
AI Panel at the 2026 Jefferies Global Healthcare Conference
Thursday, June 4, 2026
8:45am EDT

Panel discussion featuring Yujiro S. Hata, President and Chief Executive Officer, moderated by Akash Tewari, Global Head of Biopharmaceutical Research

2026 Jefferies Global Healthcare Conference
Wednesday, June 3, 2026
7:35am EDT

Fireside chat with Yujiro S. Hata, President and Chief Executive Officer, hosted by Maury Raycroft, Ph.D. Equity Research Analyst, Biotechnology

All Events